Loading patent…
AssigneeSociete des Produits Nestle S.A.
InventorsGene Bowman, Julie Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat, Claus Rieker
Estimating the term…
A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels a level selected from the group consisting of:
Method for use in reducing or preventing cognitive decline, or improving cognitive ability in a subject, comprising administering to a subject in need thereof an omega-3 fatty acid wherein the omega-3 fatty acid is administered to the subject simultaneously, sequentially or separately with vitamin D or a metabolite thereof, and/or an agent capable of reducing plasma homocysteine levels.
(canceled)
A method for reducing plasma homocysteine levels for use in reducing or preventing cognitive decline, or improving cognitive ability in a subject, comprising administering an agent capable of reducing plasma homocysteine levels is to a subject simultaneously, sequentially or separately with an omega-3 fatty acid, and/or vitamin D or a metabolite thereof.
12-21. (canceled)
Dependencies are inferred from the claim text.